We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MitoNEET: A Novel Therapeutic Target for Metabolic-based Diseases

News   Jul 04, 2019 | Original story from West Virginia University

 
MitoNEET: A Novel Therapeutic Target for Metabolic-based Diseases
 
 
Advertisement
 

RELATED ARTICLES

Proteins in the Blood of COVID-19 Patients Could Help Predict How Ill They Will Become

News

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

READ MORE

Out-of-Sync Brain Waves May Underlie Learning Deficit Linked to Schizophrenia

News

A new study has pinpointed a specific pattern of brain waves that underlies the ability to let go of old, irrelevant learned associations to make way for new updates.

READ MORE

New Study Elucidate a Molecular Mechanism That Causes Differences in Drug Addiction, Making Some More Prone

News

Researchers have discovered that dopamine D2 receptors (DRD2s) in cholinergic interneurons (ChINs) play a crucial role in cocaine addiction.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Proteomics & Metabolomics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE